Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Annual 2024 Operating Results Revenues: Revenues were $56 thousand for the year ended December 31, 2024, compared to $3.2 million for the ...
Read more
Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
Phase 3 clean clinical trial is exceeding 50 % entry with new study site activities, which is expected to be ...
Read more
